I have identified that a region in the flavivirus (dengue and related viruses) genome that is stable throughput the genus may be very variable for a given flavivirus species.
I have identified a new risk group for reactions to live yellow fever vaccine.
By analysis of viral sequences I have clarified areas in the dengue virus genome related to antibody dependent enhancement